Glucocorticoids, a mainstay therapy, for the treatment of muscle strength and function1,2
Angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) for the treatment of heart disease3
Bisphosphonate therapy for the treatment of osteoporosis3
Hormone replacement therapy for the treatment of impaired growth, delayed puberty, and adrenal insufficiency1
Mutation-specific therapies or gene replacement therapies aiming to restore dystrophin production
Muscle membrane stabilisation and/or upregulation of compensatory proteins which are structurally and functionally similar to dystrophin
Reduction of the inflammatory cascade and/or enhancement of muscle regeneration
*Some of these treatments have been approved by regulators while others are near, or in regulatory review or in clinical trials and might become available in the future1,4
Duchenne International Care Considerations highlight that physiotherapy and glucocorticoids remain the mainstays of treatment for Duchenne muscular dystrophy – click here to learn more.
(excluding UK and Ireland)
Not a healthcare professional but want to know more? Visit Duchenne and You for more information on signs and symptoms of Duchenne, diagnosis and support following a Duchenne diagnosis
Please ensure all questions are answered before submitting
When providing your feedback, no personal information will be collected, linked or shared with other parties, websites or social media platforms.
Thank you for submitting your response!
In addition to cookies that are necessary to operate this website, we use optional cookies to provide website functionality and give you the best possible experience. We won't set optional cookies unless you enable them. For more detailed information see our Cookie Statement , which explains among others, how to set your cookie preferences and how to recall your consent.